View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Barnes & Noble Education Reports Third Quarter Fiscal Year 2025 Financ...

Barnes & Noble Education Reports Third Quarter Fiscal Year 2025 Financial Results BNC First Day® Program Revenues Increased 21% YOY to $222 Million Total Revenue Growth of 2% and Gross Comparable Store Sales Growth of 7% Net Income Improves by $17 Million to $7 Million Adjusted EBITDA Improves by $6 Million to $27 Million BASKING RIDGE, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- , (“Barnes & Noble Education,” “BNED,” the “Company,” “we,” “us,” “our”), a leading solutions provider for the education industry, today reported sales and earnings for the third quarter ended on January 25, 202...

 PRESS RELEASE

Barnes & Noble Education Strengthens Leadership Team with the Appointm...

Barnes & Noble Education Strengthens Leadership Team with the Appointment of Christopher Neumann as General Counsel & Corporate Secretary and Gary Luster as Chief Accounting Officer BASKING RIDGE, N.J., March 06, 2025 (GLOBE NEWSWIRE) --  (NYSE: BNED), a leading solutions provider for the education industry, today announced the appointment of Christopher Neumann as General Counsel & Corporate Secretary and Gary Luster as Chief Accounting Officer, effective March 3, 2025. Christopher Neumann – General Counsel & Corporate SecretaryMr. Neumann joins BNED from Six Flags — a NYSE listed publi...

 PRESS RELEASE

Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read ...

Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C New website launched in honor of Rare Disease Day, Feb. 28, 2025 Awareness campaign includes educational resources and testing information for individuals with suspected NPC. CELEBRATION, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies to people living with rare disease, today announced, on Rare Disease ...

 PRESS RELEASE

Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease...

Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million CELEBRATION, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that it has entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $150 million upon the closing of the transaction, which is expected to take place within 30 to 45 days...

 PRESS RELEASE

Zevra to Report 2024 Fourth Quarter and Full Year Financial Results

Zevra to Report 2024 Fourth Quarter and Full Year Financial Results Company will host conference call on Tuesday, Mar. 11, 2025, at 4:30 p.m. ET CELEBRATION, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the fourth quarter and full year 2024 on Tuesday, Mar. 11, 2025. The Company will issue a news release after the market closes and host a conference call/audio webcas...

 PRESS RELEASE

Zevra to Participate at Upcoming Investor Conferences

Zevra to Participate at Upcoming Investor Conferences CELEBRATION, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate at the following March events: TD Cowen 45th Annual Health Care Conference on Wednesday, Mar. 5, 2025, at 10:30 a.m. ET.37th Annual ROTH Conference on Monday, Mar. 17, 2025, at 1:00 p.m. PT. Additionally, management will be available for one...

Paycom Software Inc: 1 director

A director at Paycom Software Inc sold 1,500 shares at 210.570USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

 PRESS RELEASE

Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™

Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™ Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposium Eight abstracts discussing data and clinical experience associated with MIPLYFFA accepted for poster presentation, with one poster selected for oral presentation by Dr. Eugen Mengel CELEBRATION, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that eight abstracts discussing data and clinical ex...

 PRESS RELEASE

Zevra Therapeutics to Participate at Upcoming Investor Conferences

Zevra Therapeutics to Participate at Upcoming Investor Conferences CELEBRATION, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra’s executive leadership team will participate in the following February events. Guggenheim Securities SMID Cap Biotechnology Conference on Wednesday, Feb. 5, 2025, at 2:30 p.m. ET.Oppenheimer & Co. 35th Annual Healthcare Life Sciences Conference on Wednesday, Feb. 12, 2025, at 3:20 p.m. ET. Additionally, managemen...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: January 11, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 10, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 7, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 6, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: January 4, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: January 2, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 31, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 28, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 21, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

COP CONOCOPHILLIPS
OXY OCCIDENTAL PETROLEUM CORPORATION
HPP HUDSON PACIFIC PROPERTIES INC.
VRSN VERISIGN INC.
TTSH TILE SHOP HOLDINGS INC.
RMAX RE/MAX HOLDINGS INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
PBF PBF ENERGY INC. CLASS A
NMFC NEW MOUNTAIN FINANCE CORPORATION
MTDR MATADOR RESOURCES COMPANY
MMS MAXIMUS INC.
DLY LYONDELLBASELL INDUSTRIES NV
KVHI KVH INDUSTRIES INC.
HRZN HORIZON TECHNOLOGY FINANCE CORP.
GLP GLOBAL PARTNERS LP
FPI FARMLAND PARTNERS REIT
FISI FINANCIAL INSTITUTIONS INC.
FFIC FLUSHING FINANCIAL CORP.
CNC CENTENE CORPORATION
CULP CULP INC.
FI FRANK'S INTERNATIONAL NV
NSC NORFOLK SOUTHERN CORPORATION
PETS PETMED EXPRESS INC.
PLSE PULSE BIOSCIENCES
SENS SENSEONICS HOLDINGS
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
TDW TIDEWATER INC
DOW DOW INC.
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
BCYC BICYCLE THERAPEUTICS
OXLC OXFORD LANE CAPITAL CORP.
PHAT PHATHOM PHARMACEUTICALS
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
REYN REYNOLDS CONSUMER PRODUCTS INC.
PRLD PRELUDE THERAPEUTICS
DLHC DALEIGH HOLDINGS CORP
MASS 908 DEVICES
CTGO CONTANGO ORE INC.
UAN CVR PARTNERS LP
PFX PHENIXFIN CORP
RMBL RUMBLEON INC
XLO XILIO THERAPEUTICS INC
NVCT NUVECTIS PHARMA INC
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BHRB BURKE & HERBERT BANK & TR/VA
ECBK ECB BANCORP INC.
DINO HF SINCLAIR CORP
TKO TKO GROUP HOLDINGS
GAM INC.
MIO GENERAL DE ALQUILER DE MAQUINARIA
SUNS PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
MDRR SUNRISE REALTY TRUST
SIRI MEDALIST DIVERSIFIED REIT INC.
EVM SIRIUS XM HLDGS INC NEW
TXO EATON VANCE INSD CALIF MUN BD FD
MORNINGSTAR PARTNERS
L.P.
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 20, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch